Russian COVID vaccine could be produced in China, India: Putin
Moscow: President Vladimir Putin on Tuesday called for a joint effort by the Brics countries on the development of Covid-19 vaccines as he suggested that Russia's Sputnik V vaccine could be produced in China and India, which are members of the five-nation bloc.
"We believe it is important to speed up the establishment of the centre for development and research of BRICS vaccines, which we agreed to do two years ago, upon the initiative of our South African friends," Putin said while addressing the 12th BRICS summit via videoconferencing.
The summit, hosted by President Putin, was attended by Prime Minister Narendra Modi, Chinese President Xi Jinping, Brazilian President Jair Bolsonaro and South African President Cyril Ramaphosa.
Putin said that Russia's Sputnik V vaccine that was registered in August could be produced in China and India, both members of the BRICS, Sputniknews reported.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.